Fig. 1From: Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinibStudy design. NTRK neurotrophic tyrosine receptor kinase, TRK tropomyosin receptor kinaseBack to article page